Remove 2023 Remove Cerebrovascular Disease Remove Stroke
article thumbnail

International Stroke Conference Researcher Finds AI-based System Helped Guide Treatment, Lowered Stroke Recurrence

DAIC

Image courtesy: Getty Images christine.book Thu, 02/08/2024 - 15:53 February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association ’s International Stroke Conference , ISC 2024 , shed light on the use of artificial intelligence ( AI ) to help guide treatment decisions for stroke patients.

Stroke 105
article thumbnail

Abstract TP280: Monogenetic Stroke Syndrome Testing in Adults: A Single Center Experience

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page ATP280-ATP280, February 1, 2024. As access and coverage of genetic testing has increased, it is being used more commonly in adults with strokes. Indications for testing included evaluation of carotid and vertebral dissections, recurrent stroke, cryptogenic stroke, and leukoencephalopathy.

Stroke 40
article thumbnail

Dialysis Modality and Incident Stroke Among Patients With End-Stage Kidney Disease: A Registry-Based Cohort Study

Stroke Journal

Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. The primary outcome was incident acute ischemic stroke.

article thumbnail

Abstract 269: Promoting Access to Vascular Neurology Services in Underserved Areas of Africa

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionStroke is the most common manifestation of cerebrovascular disease, which requires prompt diagnosis and treatment. Stroke is one of the major causes of dementia, disability, and mortality worldwide.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

article thumbnail

Abstract WP222: Basilar Artery Stenosis in Children With Moyamoya

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. In our cohort 7.2%

article thumbnail

Abstract 117: Digitally Subtracted Angiogram & Biopsy Negative Recurrent Spontaneous Bilateral Anterior Cerebral Artery Territory Intracranial Hemorrhage

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The patient was diagnosed with ACA territory stroke complicated by PH2‐type hemorrhagic conversion. She improved clinically and was discharged to rehab with a diagnosis of recurrent hemorrhage attributed to anticoagulant use and recent stroke.